Reaktion #307769
ord-08868d7810924327b6e6b5612e5f4bc3
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1Sonstige, then purify by SCX-2® chromatography
- 2Waschenwashing with methanol
- 3WaschenElute with 2 M ammonia in methanol
- 4Einengenconcentrate
- 5SonstigePurify by low pH reverse phase HPLC
- 6Sonstigeform the free base
- 7Waschenwashing with methanol
- 8Waschenthen eluting with 2 M ammonia in methanol
- 9Einengenconcentrate
- 10workup.DISSOLUTIONDissolve the free base in acetonitrile
- 11workup.ADDITIONby adding 2 M aq HCl solution
Vorschrift
Dissolve 3′-chloro-4-(1,5-dimethyl-1H-pyrazol-4-ylmethyl)-3,4,5,6-tetrahydro-2H-[1,2′]bipyrazinyl (307 mg, 1.0 mmol) in N,N-dimethylacetamide (4 mL). Add potassium carbonate (332 mg, 2.4 mmol), 2-methyl-2-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propionitrile (300 mg, 1.2 mmol), tetrakis(triphenylphosphine)palladium(0) (0.0050 g, 0.0058 mmol), then water (2 mL) and degas with nitrogen for 10 min. Heat at 120° C. for 20 hr., then purify by SCX-2® chromatography washing with methanol. Elute with 2 M ammonia in methanol and concentrate. Purify by low pH reverse phase HPLC, then form the free base by passing through an SCX-2® ion exchange cartridge washing with methanol then eluting with 2 M ammonia in methanol and concentrate. Dissolve the free base in acetonitrile and convert to the hydrochloride salt by adding 2 M aq HCl solution. Add water and lyophilize to give the title compound as a light yellow powder (158 mg, 35%). MS (ES): m/z=416 [M+H]+.